As we enter a new wave of drug discovery,
- explore the clinical viability of protein degraders including discussions on delivery methods, optimisation strategies and DMPK & SAR parameters.
- learn how multispecifics that form connections between POIs and cellular machinery are expanding drug amenability of proteins in this untapped, new wave of medicine.
- reach “undruggable” high-hanging fruit using chemoproteomics platforms including DNA encoded libraries and covalent ligand discovery.
2021 is set to be another showstopper for targeted protein degradation with 15 compounds predicted to enter the clinic by the end of the year.
 
Make sure you attend the largest protein degradation congress in Europe to ensure you’re reaping the benefits of this drug revolution.
 
Note that all sessions can be watched on-demand post conference in case you are unable to join them live!